title: Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C.
abstract: Oxidative stress plays a major role in the pathogenesis and in the onset of macrovascular complications of diabetes. We previously reported that the antihyperglycaemic drug metformin was able to decrease significantly intracellular reactive oxygen species (ROS) production of bovine aortic endothelial cells (BAEC) activated by high levels of glucose and angiotensin II (ANG). The aim of the present study was to investigate whether the antioxidant effect of metformin on BAEC could be mediated through a modulation of protein kinase C (PKC) activity, which plays a key role in the pathophysiology of diabetes. The effects of metformin on intracellular ROS production, PKC translocation and activity were studied on endothelial cells stimulated by PMA (a direct PKC activator), ANG or high levels of glucose as pathophysiological stimuli of endothelial dysfunction in diabetes. We showed that metformin decreased ROS production on PMA-, ANG- and glucose-stimulated BAEC in a similar manner to that obtained by PKC specific inhibitors (calphostin C, chelerythrine) alone. On the other hand, metformin reduced both PKC membrane translocation and kinase activity in ANG-stimulated cells. In PMA-activated cells, metformin reduced membrane PKC activity but we did not observe any alteration of PKC membrane translocation. Finally, in vitro incubation with purified PKC indicated that metformin had no direct effect on PKC activity. Taken together, our results suggest that metformin exerted intracellular antioxidant properties by decreasing ROS production through the inhibition of PKC activity.
authors.affiliation: EA 3617 Stress Oxydant et Atteintes Vasculaires, Département de Biochimie, Faculté de Pharmacie, 4, Avenue de l'Observatoire, F75006 Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Mahrouf
authors.forename: N
authors.initials: N
authors.lastname: Ouslimani
authors.forename: J
authors.initials: J
authors.lastname: Peynet
authors.forename: R
authors.initials: R
authors.lastname: Djelidi
authors.forename: M
authors.initials: M
authors.lastname: Couturier
authors.forename: P
authors.initials: P
authors.lastname: Therond
authors.forename: A
authors.initials: A
authors.lastname: Legrand
authors.forename: J-L
authors.initials: JL
authors.lastname: Beaudeux
mesh_terms: D000809:Angiotensins / Q000494:pharmacology*; D000818:Animals; D015153:Blotting, Western; D002417:Cattle; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D004789:Enzyme Activation; D008687:Metformin / Q000494:pharmacology*; D019255:NADPH Oxidases / Q000378:metabolism; D011493:Protein Kinase C / Q000037:antagonists & inhibitors* / Q000378:metabolism; D021381:Protein Transport; D017382:Reactive Oxygen Species / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
chemical_list: D000809:Angiotensins; D017382:Reactive Oxygen Species; D008687:Metformin; D019255:NADPH Oxidases; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate